Physician profile
Eric M Sievers
NPI 1629222427
$6,953.66
in general payments reported to CMS, 2019-2025
26 companies · $1,840 in 2025
The $1,840 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,702 · 2020: $612 · 2021: $586 · 2022: $582 · 2023: $309 · 2024: $323 · 2025: $1,840.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,015 · Travel and Lodging: $457.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,015.46 |
| Travel and Lodging | $456.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $3,093.35 | 2019-2025 | Impella |
| Atricure, INC. | $684.61 | 2019-2025 | Epi-Sense Guided Coagulation System With Visitrax, Synergy Ablation System |
| Edwards Lifesciences Corporation | $639.66 | 2020-2025 | Inspiris Resilia Aortic Valve, Mitris Resilia Mitral Valve |
| Endologix LLC | $624.82 | 2019 | |
| Medtronic, INC. | $377.90 | 2021-2025 | Corevalve Evolut R |
| Medtronic Vascular, INC. | $316.45 | 2020 | |
| Artivion, INC. | $191.08 | 2019-2025 | On-X Aortic Heart Valve With Conform-X Sewing Ring and Extended Holder, Bioglue Surgical Adhesive |
| W. L. Gore & Associates, INC. | $187.91 | 2019 | |
| Silk Road Medical, INC. | $163.39 | 2021-2023 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent |
| Intuitive Surgical, INC. | $128.71 | 2019 | |
| Gentleman Orthopedic Solutions | $120.29 | 2022-2025 | |
| Zimmer Biomet Holdings, INC. | $67.78 | 2019 | |
| Bolton Medical INC | $59.78 | 2023 | Treo Abdominal Stent-Graft System |
| Becton, Dickinson and Company | $40.74 | 2025 | Hemosphere |
| Chiesi USA, INC. | $39.06 | 2020-2024 | Cleviprex, Kengreal |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Elutia, INC. | $33.74 | 2019 | |
| Lsi Solutions INC | $33.36 | 2024-2025 | Cor-Knot |
| Livanova USA, INC. | $23.84 | 2019 | |
| Portola Pharmaceuticals, LLC | $22.29 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $21.02 | 2019 | |
| Kls-Martin L.P. | $15.93 | 2024 | |
| Nuwellis, INC. | $15.30 | 2019 | |
| Angiodynamics, INC. | $14.69 | 2019 | |
| Abbott Laboratories | $13.70 | 2022 | |
| Covidien LP | $12.78 | 2019 | |
| Veran Medical Technologies, INC. | $11.48 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Sievers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.